Delivery Order SPE2DB20D1109-SPE2DB24FP18H

Award Date 5/16/24
Potential Completion Date 5/17/24
Potential Value $23K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of lidocaine 5% patches to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, and has a ceiling value of $3,367.16. The contract is a delivery order with a firm fixed-price pricing type and an ultimate completion date of July 19, 2024. The contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract...
This federal contract award is for the delivery of Lidocaine 5% Patch 30s to the Defense Logistics Agency (DLA). The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, and has a total ceiling value of $2,486.40. The contract has an ultimate completion date of April 26, 2024. The award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. This IDC, valued at up...
This federal contract award is for the delivery of Lidocaine 5% Patch 30s medical products to the Defense Logistics Agency (DLA), a defense agency under the U.S. Department of Defense. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, on May 21, 2024, with a ceiling value of $2,666.94. The contract is a delivery order with a firm fixed price, and the ultimate completion date is May 22, 2024. This contract is not a set-aside award....
This federal contract award is for the delivery of Lidocaine 5% Patch 30s to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on February 5, 2025, with a completion date of February 6, 2025. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $1,969.60. The award is not designated as a set-aside contract. AmerisourceBergen holds a significant Indefinite Delivery Contract...
This federal contract award is for the delivery of Lidocaine 5% Patch 30s to the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense. The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, and has a ceiling value of $3,277.54. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of June 24, 2024. No set-aside designation was used for this...
This federal contract award is for the delivery of Lidocaine 5% Patch 30s to the Defense Logistics Agency (DLA). The contract, valued at $15,726.93, was awarded to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a firm fixed price pricing type and an ultimate completion date of January 8, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop...
This federal contract award is for the delivery of Lidocaine 5% Patches to the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense. The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on June 25, 2024, with a ceiling value of $19,127.25. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of June 26, 2024. The contract does not have a...
This federal contract award is for the delivery of Lidocaine 5% Patches, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on May 28, 2024 with a ceiling value of $1,870.47 and a completion date of May 29, 2024. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical,...
This federal contract award is for the delivery of Lidocaine 5% Patch 30s, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on July 23, 2024 with a ceiling value of $11,303.00. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of July 24, 2024. This award is not designated with a set-aside. AmerisourceBergen holds a significant...
This federal contract award is for the delivery of Lidocaine 5% Patch 30s to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price pricing type, has a ceiling value of $11,094.15, and an ultimate completion date of January 28, 2025. This award is not associated with a set-aside designation. Amerisourcebergen...
  • SPE2DB20D1109
    Indefinite Delivery Contract
  • SPE2DB20D1109-SPE2DB24FP18H
    Delivery Order

This federal contract award is for the delivery of Lidocaine 5% Patch 30s to the Defense Logistics Agency (DLA), a defense agency. The fixed-price delivery order contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract has a ceiling value of $22,760.84 and a completion date of May 17, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 through November 2026. The IDC serves as a comprehensive vehicle for providing a wide range of pharmaceutical products and medical supplies to support military healthcare programs globally. There is no set-aside designation for this particular award.

Generated 5/16/25, 11:42 AM